Ledger.Open graph →
SEC Form D · Amendment · filed January 23, 2014

Altheus Therapeutics Inc

Offering
$8.1M
Sold
$8.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OKLAHOMA CITY, OK
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Richard F. Harty, Md · Oklahoma City, OKExecDouglas A. Branch · Oklahoma City, OKDirectorDennis Schafer · Oklahoma City, OKExec · DirectorWilliam L. Paiva · Tulsa, OKDirectorThomas L. Shoaf · St. Louis, MODirectorDayton T. Reardan · Oklahoma City, OKExecBrian L. Clevinger · St. Louis, MODirectorDeborah A. Farrington · NEW YORK, NYExecJohn W. Sinnenberg · CLEVELAND, OHDirectorPhilip S. Curatilo · CLEVELAND, OHExec · DirectorTed R. Laufik · CLEVELAND, OHDirectorW. P. Rond · CLEVELAND, OHDirectorDaniel J. Kessler · CLEVELAND, OHExecBeth H. Laschinger · CLEVELAND, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗